In fiscal year 2025, Eutilex (263050) reported revenue of 10.3 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 10.3 billion KRW | -18.9 billion KRW | -25.8 billion KRW | [source] |
| 2024 | 9.5 billion KRW | -26.5 billion KRW | -29.5 billion KRW | [source] |
| 2023 | 132 million KRW | -29.8 billion KRW | -28.3 billion KRW | [source] |
| 2022 | 216 million KRW | -36.7 billion KRW | -34.5 billion KRW | [source] |
| 2021 | — | -33.6 billion KRW | -29.6 billion KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 40.8 billion KRW | 25.2 billion KRW | 15.6 billion KRW | [source] |
| 2024 | 62.3 billion KRW | 26.1 billion KRW | 36.2 billion KRW | [source] |
| 2023 | 67.3 billion KRW | 12.2 billion KRW | 55.1 billion KRW | [source] |
| 2022 | 97.7 billion KRW | 15.7 billion KRW | 82.0 billion KRW | [source] |
| 2021 | 102.2 billion KRW | 41.5 billion KRW | 60.8 billion KRW | [source] |
This company has no revenue account in the DART financial statements. Industry-specific accounts such as insurance or interest income are not converted to revenue.